Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Nov;6(4):331-6.
doi: 10.1007/s12519-010-0207-y. Epub 2010 Jun 12.

Prevalence of childhood asthma and allergies in Serbia and Montenegro

Affiliations
Multicenter Study

Prevalence of childhood asthma and allergies in Serbia and Montenegro

Zorica Zivković et al. World J Pediatr. 2010 Nov.

Abstract

Background: This is the first multi-center epidemiological study on the prevalence of childhood asthma in Serbia and Montenegro. The International Study of Asthma and Allergies in Childhood (ISAAC) phase 3 is a large epidemiological multinational and multicentric study on the prevalence of asthma, allergic rhinitis and eczema in children.

Methods: The 12-month period prevalence of asthma, allergic rhinitis and eczema was calculated using an ISAAC phase 3 questionnaire for two age groups: 6-7 years old and 13-14 years old.

Results: In the 13 485 children from five study centers who responded to the questionnaire, the prevalence for childhood asthma ranged from 2.5% to 9.8%, for allergic rhinoconjunctivitis (hay fever) from 4.6% to 21%, and for eczema from 8.2% to 17.2%. The prevalence of current wheezing was high in both age groups (16.5% and 12.4% respectively).

Conclusions: The prevalence of asthma is higher in 6-7 years old school children in the urban and largest cities of Belgrade and Nis, and in 13-14 years old children in Podgorica. The prevalence of asthma, allergic rhinitis and eczema in the school children of Serbia and Montenegro seems similar to that of other countries in Central and South-Eastern Europe.

PubMed Disclaimer

References

    1. Eur Respir J. 2000 Jul;16(1):86-90 - PubMed
    1. Lancet. 1998 Apr 25;351(9111):1225-32 - PubMed
    1. Eur Respir J. 1998 Aug;12(2):315-35 - PubMed
    1. Clin Exp Allergy. 2004 Jul;34(7):1007-10 - PubMed
    1. Thorax. 2007 Sep;62(9):758-66 - PubMed

Publication types